Perdomo, Carolina M. http://orcid.org/0000-0002-5748-0581
Avilés-Olmos, Icíar http://orcid.org/0000-0002-1645-7406
Dicker, Dror http://orcid.org/0000-0001-8546-6245
Frühbeck, Gema http://orcid.org/0000-0002-8305-7154
Funding for this research was provided by:
Instituto de Salud Carlos III (PI22/00745)
Universidad de Navarra
Article History
Accepted: 10 March 2023
First Online: 10 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: DD reports speaker and Advisory fee from: Novonordisk, Lilly, BI, Astra Zenca. CMP reports speaker fees from Novo Nordisk. GF reports research grants paid to her Institution from the Carlos III Health Institute. GF reports payment or honoraria for attendance to the 2022 Lilly Diabetes Global Medical Affairs Portfolio Advisory Board. GF is member of the OPEN Spain Initiative. GF is a co-chair of the Scientific Advisory Board of the European Association for the Study of Obesity—it is an unpaid position.